DRKS00006297
Recruiting
Not Applicable
Dynamic of tumor hypoxia before, during and after radiotherapy as assessed by biomarker analysis in patient serum
Klinik für Radio-OnkologieUniversitätsSpital Zürich0 sites300 target enrollmentJuly 11, 2014
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancers of different origin
- Sponsor
- Klinik für Radio-OnkologieUniversitätsSpital Zürich
- Enrollment
- 300
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •NSCLC treated with stereotactic body radiotherapy or nomally fractionated radiotherapy. In addition, patients with cancers of different origin and treated with SBRT may also be included for biomarker analysis.
Exclusion Criteria
- •Postoperative radiotherapy. Pregnant or lactating women.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
The significance of changes in tumor hypoxia by anti-PD-1 / PD-L1 antibody therapy for advanced non-small cell lung cancer.advanced non-small cell lung cancerJPRN-UMIN000041659Saitama Medical University International Medical Center20
Completed
Not Applicable
Dynamics of tumour hypoxia and metabolism during Chemoradiotherapy for stage III Non Small Cell Lung Cancer, using 18F-FAZA-PET/CT and 18F-FDG-PET/CT. A Pilot Studynon-small-cell-lung-cancer10038666NL-OMON39397niversitair Medisch Centrum Groningen10
Completed
Not Applicable
Assessment of tumor hypoxia during radiotherapy course in locally advanced Head and Neck cancer with 18F-fluoroazomycin arabinoside (18F-FAZA)-PET-CThoofd hals kankerHypoxia in locally advanced Head and Neck cancer10027656NL-OMON36574niversitair Medisch Centrum Groningen20
Terminated
Phase 2
Tumor Hypoxia With HX4 PET in Several DiseasesProstatic NeoplasmsEsophageal NeoplasmsNeoplasm Metastases, BrainRectal NeoplasmsBrain Neoplasm, PrimaryNCT02584400Maastricht Radiation Oncology1
Completed
Not Applicable
Tumor hypoxia measured with F-MISO-PET in the course of irradiation of head and neck cancer: adoption of the method into clinical routine and evaluation of the dataC10C13Malignant neoplasm of oropharynxMalignant neoplasm of hypopharynxDRKS00006007niversitätsklinikum DresdenKlinik für Strahlentherapie und Radioonkologie59